These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23879244)

  • 1. Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes.
    Drougard A; Duparc T; Brenachot X; Carneiro L; Gouazé A; Fournel A; Geurts L; Cadoudal T; Prats AC; Pénicaud L; Vieau D; Lesage J; Leloup C; Benani A; Cani PD; Valet P; Knauf C
    Antioxid Redox Signal; 2014 Feb; 20(4):557-73. PubMed ID: 23879244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice.
    Duparc T; Colom A; Cani PD; Massaly N; Rastrelli S; Drougard A; Le Gonidec S; Moulédous L; Frances B; Leclercq I; Llorens-Cortes C; Pospisilik JA; Delzenne NM; Valet P; Castan-Laurell I; Knauf C
    Antioxid Redox Signal; 2011 Sep; 15(6):1477-96. PubMed ID: 21395477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin targets gut contraction to control glucose metabolism via the brain.
    Fournel A; Drougard A; Duparc T; Marlin A; Brierley SM; Castro J; Le-Gonidec S; Masri B; Colom A; Lucas A; Rousset P; Cenac N; Vergnolle N; Valet P; Cani PD; Knauf C
    Gut; 2017 Feb; 66(2):258-269. PubMed ID: 26565000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders.
    Knauf C; Drougard A; Fournel A; Duparc T; Valet P
    Horm Metab Res; 2013 Dec; 45(13):928-34. PubMed ID: 23950038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic K(ATP) channels control hepatic glucose production.
    Pocai A; Lam TK; Gutierrez-Juarez R; Obici S; Schwartz GJ; Bryan J; Aguilar-Bryan L; Rossetti L
    Nature; 2005 Apr; 434(7036):1026-31. PubMed ID: 15846348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin, diabetes, and obesity.
    Castan-Laurell I; Dray C; Attané C; Duparc T; Knauf C; Valet P
    Endocrine; 2011 Aug; 40(1):1-9. PubMed ID: 21725702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic α-MSH release.
    Reaux-Le Goazigo A; Bodineau L; De Mota N; Jeandel L; Chartrel N; Knauf C; Raad C; Valet P; Llorens-Cortes C
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E955-66. PubMed ID: 21846903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice.
    Tsuneki H; Nagata T; Fujita M; Kon K; Wu N; Takatsuki M; Yamaguchi K; Wada T; Nishijo H; Yanagisawa M; Sakurai T; Sasaoka T
    Endocrinology; 2016 Jan; 157(1):195-206. PubMed ID: 26492471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 11. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus.
    Duparc T; Naslain D; Colom A; Muccioli GG; Massaly N; Delzenne NM; Valet P; Cani PD; Knauf C
    Antioxid Redox Signal; 2011 Feb; 14(3):415-23. PubMed ID: 20879900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism.
    Jaillard T; Roger M; Galinier A; Guillou P; Benani A; Leloup C; Casteilla L; Pénicaud L; Lorsignol A
    Diabetes; 2009 Jul; 58(7):1544-9. PubMed ID: 19389827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats.
    Park S; Hong SM; Ahn IS
    Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
    Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
    Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons.
    Cady G; Landeryou T; Garratt M; Kopchick JJ; Qi N; Garcia-Galiano D; Elias CF; Myers MG; Miller RA; Sandoval DA; Sadagurski M
    Mol Metab; 2017 May; 6(5):393-405. PubMed ID: 28462074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles.
    Woitiski CB; Neufeld RJ; Soares AF; Figueiredo IV; Veiga FJ; Carvalho RA
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1441-50. PubMed ID: 22324290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
    O'Carroll AM; Lolait SJ; Harris LE; Pope GR
    J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity.
    Delaere F; Magnan C; Mithieux G
    Diabetes Metab; 2010 Sep; 36(4):257-62. PubMed ID: 20561808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels.
    Kinote A; Faria JA; Roman EA; Solon C; Razolli DS; Ignacio-Souza LM; Sollon CS; Nascimento LF; de Araújo TM; Barbosa AP; Lellis-Santos C; Velloso LA; Bordin S; Anhê GF
    Endocrinology; 2012 Aug; 153(8):3633-45. PubMed ID: 22585831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.